Cargando…
Different significance of HRCT and FDG-PET/CT to predict lymph node status between patients with clinical stage IA lung adenocarcinoma and squamous cell carcinoma
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4695719/ http://dx.doi.org/10.1186/1749-8090-10-S1-A332 |
_version_ | 1782407676715597824 |
---|---|
author | Tsutani, Yasuhiro Miyata, Yoshihiro Mimura, Takeshi Ito, Masaoki Kai, Yuichiro Kagimoto, Atsushi Nakayama, Haruhiko Okumura, Sakae Yoshimura, Masahiro Okada, Morihito |
author_facet | Tsutani, Yasuhiro Miyata, Yoshihiro Mimura, Takeshi Ito, Masaoki Kai, Yuichiro Kagimoto, Atsushi Nakayama, Haruhiko Okumura, Sakae Yoshimura, Masahiro Okada, Morihito |
author_sort | Tsutani, Yasuhiro |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-4695719 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-46957192016-01-07 Different significance of HRCT and FDG-PET/CT to predict lymph node status between patients with clinical stage IA lung adenocarcinoma and squamous cell carcinoma Tsutani, Yasuhiro Miyata, Yoshihiro Mimura, Takeshi Ito, Masaoki Kai, Yuichiro Kagimoto, Atsushi Nakayama, Haruhiko Okumura, Sakae Yoshimura, Masahiro Okada, Morihito J Cardiothorac Surg Meeting Abstract BioMed Central 2015-12-16 /pmc/articles/PMC4695719/ http://dx.doi.org/10.1186/1749-8090-10-S1-A332 Text en Copyright © 2015 Tsutani et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Meeting Abstract Tsutani, Yasuhiro Miyata, Yoshihiro Mimura, Takeshi Ito, Masaoki Kai, Yuichiro Kagimoto, Atsushi Nakayama, Haruhiko Okumura, Sakae Yoshimura, Masahiro Okada, Morihito Different significance of HRCT and FDG-PET/CT to predict lymph node status between patients with clinical stage IA lung adenocarcinoma and squamous cell carcinoma |
title | Different significance of HRCT and FDG-PET/CT to predict lymph node status between patients with clinical stage IA lung adenocarcinoma and squamous cell carcinoma |
title_full | Different significance of HRCT and FDG-PET/CT to predict lymph node status between patients with clinical stage IA lung adenocarcinoma and squamous cell carcinoma |
title_fullStr | Different significance of HRCT and FDG-PET/CT to predict lymph node status between patients with clinical stage IA lung adenocarcinoma and squamous cell carcinoma |
title_full_unstemmed | Different significance of HRCT and FDG-PET/CT to predict lymph node status between patients with clinical stage IA lung adenocarcinoma and squamous cell carcinoma |
title_short | Different significance of HRCT and FDG-PET/CT to predict lymph node status between patients with clinical stage IA lung adenocarcinoma and squamous cell carcinoma |
title_sort | different significance of hrct and fdg-pet/ct to predict lymph node status between patients with clinical stage ia lung adenocarcinoma and squamous cell carcinoma |
topic | Meeting Abstract |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4695719/ http://dx.doi.org/10.1186/1749-8090-10-S1-A332 |
work_keys_str_mv | AT tsutaniyasuhiro differentsignificanceofhrctandfdgpetcttopredictlymphnodestatusbetweenpatientswithclinicalstageialungadenocarcinomaandsquamouscellcarcinoma AT miyatayoshihiro differentsignificanceofhrctandfdgpetcttopredictlymphnodestatusbetweenpatientswithclinicalstageialungadenocarcinomaandsquamouscellcarcinoma AT mimuratakeshi differentsignificanceofhrctandfdgpetcttopredictlymphnodestatusbetweenpatientswithclinicalstageialungadenocarcinomaandsquamouscellcarcinoma AT itomasaoki differentsignificanceofhrctandfdgpetcttopredictlymphnodestatusbetweenpatientswithclinicalstageialungadenocarcinomaandsquamouscellcarcinoma AT kaiyuichiro differentsignificanceofhrctandfdgpetcttopredictlymphnodestatusbetweenpatientswithclinicalstageialungadenocarcinomaandsquamouscellcarcinoma AT kagimotoatsushi differentsignificanceofhrctandfdgpetcttopredictlymphnodestatusbetweenpatientswithclinicalstageialungadenocarcinomaandsquamouscellcarcinoma AT nakayamaharuhiko differentsignificanceofhrctandfdgpetcttopredictlymphnodestatusbetweenpatientswithclinicalstageialungadenocarcinomaandsquamouscellcarcinoma AT okumurasakae differentsignificanceofhrctandfdgpetcttopredictlymphnodestatusbetweenpatientswithclinicalstageialungadenocarcinomaandsquamouscellcarcinoma AT yoshimuramasahiro differentsignificanceofhrctandfdgpetcttopredictlymphnodestatusbetweenpatientswithclinicalstageialungadenocarcinomaandsquamouscellcarcinoma AT okadamorihito differentsignificanceofhrctandfdgpetcttopredictlymphnodestatusbetweenpatientswithclinicalstageialungadenocarcinomaandsquamouscellcarcinoma |